| Product Name | MF | CAS | Details |
|---|
| Sorafenib IMpurity | C8H10N2O2 | 1256817-30-7 | Details |
| LacosaMide iMpurity | C13H18N2O3 | 1219042-50-8 | Details |
| Lapatinib iMpurity | C26H18FN3O3 | 746591-42-4 | Details |
| Rocuronium Bromide Impurity | C27H44N2O4 | 13492-57-4 | Details |
| 4-(Cyclopropylmethoxy)-3-(difluoromethoxy) Roflumilast | C17H14Cl2F2N2O3 | 162401-43-6 | Details |
| Linagliptin iMpurity | C25H28N8O2 | 2140263-92-7 | Details |
| LenalidoMide iMpurity | Details |
| Canagliflozin iMpurity | Details |
| Vortioxetine iMpurity | C10H14BrClN2 | 853745-55-8 | Details |
| Cinacalcet HCl impurity | Details |
| Argatroban iMpurity | C13H24N6O5 | 1448417-84-2 | Details |
| Gefitinib iMpurity | C22H23ClFN3O4 | 1608115-59-8 | Details |
| LCZ Impurity | C20H25NO2 | 753421-85-1 | Details |
| N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole Sulfide | C25H22F6N4O2S | 1083100-27-9 | Details |
| EveroliMus iMpurity | 1661009-29-5 | Details |
| Erlotinib | C13H17NO7 | 1384975-87-4 | Details |
| Dabigatran Etexilate iMpurity | C25H26N8O2 | 1643377-48-3 | Details |
| Blonanserin iMpurity | C23H30FN3 | 132810-83-4 | Details |
| Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one] | C10H7F2N3O | 1449785-88-9 | Details |
| Istradefylline iMpurity | Details |
| Conivaptan Hydrochloride Impurity | Details |
| Benidipine Impurity | C12H11NO5 | 52604-00-9 | Details |
| Fosaprepitant Impurity 5 | C21H19F6NO3 | 327623-35-8 | Details |
| Clevidipine Butyrate Impurities | Details |
| Vildagliptin iMpurity A-F | C7H10N2O3 | 1846606-32-3 | Details |
| Esomeprazole Impurity | Details |
| Loflupheniric acid hydrochloride | Details |
| 6-?amino-7-[(tetrahydro-3-furanyl)oxy]-4(3H)-Quinazolinone | C12H13N3O3 | 1405180-57-5 | Details |
| 2,2'-Bisnalmefene | C42H48N2O6 | 176220-84-1 | Details |
| Pazopanib iMpurity | Details |
| Methyl 4-Methylcinnamate | C11H12O2 | 7560-43-2 | Details |
| NA | Details |
| 1-cyclopropyl-6-fluoro-1,4-dihydro-7-((4aR,7aS)-octahydropyrrolo [3,4-b]pyridin-6-yl)-8-Methoxy-4-oxoquinoline-3-carboxylic acid | C21H24FN3O4 | 1394029-14-1 | Details |
| 2-[(2-Hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxylic Acid | C13H12N2O6S | 1809272-85-2 | Details |
| Retigabine Dihydrochloride Impurity | C16H19ClFN3O2 | 1432063-93-8 | Details |
| Indacaterol IMrity | C24H28N2O3 | 1235445-80-3 | Details |
| (S)-2-((6-(3-aMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile | C18H25N3O2 | 1353254-15-5 | Details |
| Dasatinib iMpurity | C22H27N7O2S | 1184919-23-0 | Details |
| IMidafenacin iMpurity | C18H20N2O2 | 503599-41-5 | Details |
| RaMelteon iMpurity | C16H20BrNO2 | 1204581-51-0 | Details |
| Rabeprazole iMpurity (Chloro interMediate) | Details |
| ethyl 4-hydroxy-2-oxopyrrolidine-1-acetate | C8H13NO4 | 62613-81-4 | Details |
| Rizatriptan IMpurity (1-(4-Hydrazinophenyl)-Methyl-1,2,4-triazole diHCl) | Details |
| Clevidipine butyrate impurity | Details |
| Product Total： Product Page： | ||||
| 1 | ||||